FDA NDC Directory · JSON-LD · Markdown

ZIEXTENZO

NDC 61314-866 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namepegfilgrastim-bmez
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761045
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsPEGFILGRASTIM (6 mg/.6mL)
Marketing started20191104
Package count1

External sources

Source: openFDA. Public-domain (CC0).